Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: Two case reports

CNS Spectrums

Volumn 12, Issue 8, 2007, Pages 596-598

  Kohen, Izchak ^a   Gordon, Marc L ^a,b   Manu, Peter ^a,b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; METOPROLOL; PHENELZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; VENLAFAXINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PSYCHOSIS; SEROTONIN SYNDROME; TREATMENT OUTCOME;

EID: 34548203244     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900021386     Document Type: Article

References (14)

1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120.
2. Karki SD, Masood GR. Combination risperidone and SSRI-induced serotonin syndrome. Ann Pharmacother. 2003;37:388-391.
3. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology. 1995;45:219-223.
4. Reeves RR, Mack EJ, Beddingfield JJ. Neurotoxic syndrome sssociated with risperidone and fluvoxamine. Ann Pharmacother. 2002;36:440-443.
5. Hamilton S, Malone K. Serotonin syndrome during treatment with paroxetine and risperidone. J Clin Psychopharmacol. 2000;20:103-105.
6. Marlowe K, Schrigel D. Quetiapine and citalopram: aetological significances in serotonin syndrome. N Z Med J. 2006;119:U2058.
7. Vena J, Dufel S, Paige T. Acute olanzapine-induced akathisia and dystonia in a patient discontinued from fluoxetine. J Emerg Med. 2006;30:311-317.
8. Kinzie E, Meltzer-Brody S. Possible seroronin syndrome with citalopram following cross-titration of clozapine to ziprasidone. Gen Hosp Psychiatry. 2005;27:223-224.
9. Haslett CD, Kumar S. Can olanzapine be implicated in causing serotonin syndrome? Psychiatry Clin Neurosci. 2002;56:533-535.
10. Duggal HS, Fetchko J. Serotonin syndrome and atypical antipsychotics. Am J Psychiatry. 2002;159:672-673.
11. Alvarez-Pérez FJ, Roca M, et al. Serotonin syndrome: report of two cases and review of the literature [Spanish]. Rev Neurol. 2005;40:159-162.
12. Radomski JW, Dursun SM, Reveley MA, Kutcher SP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses. 2000;55:218-224.
13. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;146:705-713.
14. Berry LL, Segal R, Sherrin TP, Fudge KA. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm. 1988;45:1534-1539.